image
Regencell Bioscience Holdings Limited RGC
Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - HK
Watchlist
$ 415.0
-7.69 %
$ 5.4 B
Market Cap
-1296.87
P/E
Price Target Average
--100.00%
Revenue Forecast Estimate
--
EBIT Estimate
--
Net Income Estimate
--
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Regencell Bioscience Holdings Limited
image
RGC has no price targets from Wall Street.
REVENUE FORECAST

Revenue Forecast Chart RGC

image
RGC has no estimates for Revenue Forecast.
$3.5b$3.5b$3.0b$3.0b$2.5b$2.5b$2.0b$2.0b$1.5b$1.5b$1.0b$1.0b$500.0m$500.0m$0.0$0.020152015201520152016201620172017201920192020202020212021202220222023202320242024
EBIT FORECAST

EBIT Forecast Chart RGC

image
RGC has no estimates for EBIT Forecast.
$300.0m$300.0m$250.0m$250.0m$200.0m$200.0m$150.0m$150.0m$100.0m$100.0m$50.0m$50.0m$0.0$0.0($50.0m)($50.0m)20152015201520152016201620172017201920192020202020212021202220222023202320242024
NET INCOME FORECAST

Net Income Chart RGC

image
RGC has no estimates for Net Income.
$180.0m$180.0m$160.0m$160.0m$140.0m$140.0m$120.0m$120.0m$100.0m$100.0m$80.0m$80.0m$60.0m$60.0m$40.0m$40.0m$20.0m$20.0m$0.0$0.0($20.0m)($20.0m)20152015201520152016201620172017201920192020202020212021202220222023202320242024